Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

0.05 ML ranibizumab 10 MG/ML Prefilled Syringe [Lucentis]

Known as: 0.05 ML Lucentis 10 MG/ML Prefilled Syringe, Lucentis 0.5 MG per 0.05 ML Prefilled Syringe, Lucentis 0.5 MG in 0.05 ML Prefilled Syringe 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
BackgroundIngrowth of newly formed blood and lymph vessels (angiogenesis) from the limbus region into the cornea can be treated… Expand
  • table 1
  • table 2
  • figure 1
  • figure 2
  • figure 3
Is this relevant?
2013
2013
Objectif?: decrire et analyser les pratiques diagnostiques et therapeutiques en matiere de degenerescence maculaire liee a l’âge… Expand
Is this relevant?
2013
2013
Lucentis ®(ranibizumab) far positivt utlatande fran EMA for ny indikation; grav narsynthet med karlnybildningar i gula flacken. 
Is this relevant?
2009
2009
Purpose: To report a case of retinal pigment epithelial tear after intravitreal injection of ranibizumab (Lucentis®) for retinal… Expand
Is this relevant?
2008
2008
Purpose: To evaluate the efficacy of intravitreal injection of Ranibizumab (Lucentis®) in Age-Related Macular Degeneration… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
Is this relevant?
Highly Cited
2008
Highly Cited
2008
BackgroundMacular choroidal neovascularization (CNV) is one of the most vision-threatening complications of myopia, which can… Expand
  • table 1
  • figure 1
  • figure 2
  • figure 3
Is this relevant?
2006
2006
Introduction Les etudes randomisees recentes sur les effets du Ranibizumab par injection intra-vitreenne dans le cas de… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
Is this relevant?